van Sighem A - Search Results

1

Risk of triple-class virological failure in children with HIV: a retrospective cohort study.

Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE); Castro H, Judd A, Gibb DM, Butler K, Lodwick RK, van Sighem A, Ramos JT, Warsawski J, Thorne C, Noguera-Julian A, Obel N, Costagliola D, Tookey PA, Colin C, Kjaer J, Grarup J, Chene G, Phillips A. Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE), et al. Among authors: van sighem a. Lancet. 2011 May 7;377(9777):1580-7. doi: 10.1016/S0140-6736(11)60208-0. Epub 2011 Apr 20. Lancet. 2011. PMID: 21511330 Free PMC article.

2

Mortality and progression to AIDS after starting highly active antiretroviral therapy.

van Sighem AI, van de Wiel MA, Ghani AC, Jambroes M, Reiss P, Gyssens IC, Brinkman K, Lange JM, de Wolf F; ATHENA Cohort Study Group. van Sighem AI, et al. Among authors: van de wiel ma. AIDS. 2003 Oct 17;17(15):2227-36. doi: 10.1097/00002030-200310170-00011. AIDS. 2003. PMID: 14523280

3

Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individuals.

van Sighem A, Danner S, Ghani AC, Gras L, Anderson RM, de Wolf F; ATHENA National Observational Cohort Study. van Sighem A, et al. J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):212-8. doi: 10.1097/01.qai.0000165911.97085.d0. J Acquir Immune Defic Syndr. 2005. PMID: 16186740

4

The genotypic inhibitory quotient and the (cumulative) number of mutations predict the response to lopinavir therapy.

Hoefnagel JG, van der Lee MJ, Koopmans PP, Schuurman R, Jurriaans S, van Sighem AI, Gras L, de Wolf F, Galama JM, Burger DM. Hoefnagel JG, et al. AIDS. 2006 Apr 24;20(7):1069-71. doi: 10.1097/01.aids.0000222083.44411.02. AIDS. 2006. PMID: 16603863

5

Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.

Kwong GP, Ghani AC, Rode RA, Bartley LM, Cowling BJ, da Silva B, Donnelly CA, van Sighem AI, Cameron DW, Danner SA, de Wolf F, Anderson RM. Kwong GP, et al. Among authors: van sighem ai. AIDS. 2006 Oct 3;20(15):1941-50. doi: 10.1097/01.aids.0000247115.81832.a1. AIDS. 2006. PMID: 16988515

6

CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater.

Gras L, Kesselring AM, Griffin JT, van Sighem AI, Fraser C, Ghani AC, Miedema F, Reiss P, Lange JM, de Wolf F; ATHENA, Netherlands National Observational Cohort Study. Gras L, et al. Among authors: van sighem ai. J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):183-92. doi: 10.1097/QAI.0b013e31804d685b. J Acquir Immune Defic Syndr. 2007. PMID: 17414934

7

Combination antiretroviral therapy failure and HIV super-infection.

Bezemer D, van Sighem A, de Wolf F, Cornelissen M, van der Kuyl AC, Jurriaans S, van der Hoek L, Prins M, Coutinho RA, Lukashov VV. Bezemer D, et al. Among authors: van der kuyl ac, van sighem a, van der hoek l. AIDS. 2008 Jan 11;22(2):309-11. doi: 10.1097/QAD.0b013e3282f37489. AIDS. 2008. PMID: 18097235

8

Immunologic, virologic, and clinical consequences of episodes of transient viremia during suppressive combination antiretroviral therapy.

van Sighem A, Zhang S, Reiss P, Gras L, van der Ende M, Kroon F, Prins J, de Wolf F. van Sighem A, et al. Among authors: van der ende m. J Acquir Immune Defic Syndr. 2008 May 1;48(1):104-8. doi: 10.1097/QAI.0b013e31816a1d4f. J Acquir Immune Defic Syndr. 2008. PMID: 18285709

9

A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.

Bezemer D, de Wolf F, Boerlijst MC, van Sighem A, Hollingsworth TD, Prins M, Geskus RB, Gras L, Coutinho RA, Fraser C. Bezemer D, et al. Among authors: van sighem a. AIDS. 2008 May 31;22(9):1071-7. doi: 10.1097/QAD.0b013e3282fd167c. AIDS. 2008. PMID: 18520351

10

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.

Antiretroviral Therapy Cohort Collaboration. Antiretroviral Therapy Cohort Collaboration. Lancet. 2008 Jul 26;372(9635):293-9. doi: 10.1016/S0140-6736(08)61113-7. Lancet. 2008. PMID: 18657708 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters